Estée Lauder Companies (EL) Competitors

Estée Lauder Companies (NYSE:EL) and Prestige Consumer Healthcare (NYSE:PBH) are both consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Is EL or PBH a better dividend stock?

Estée Lauder Companies pays an annual dividend of $1.40 per share and has a dividend yield of 2.4%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.3%. Estée Lauder Companies pays out -71.8% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 44.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Estée Lauder Companies is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has more risk & volatility, EL or PBH?

Estée Lauder Companies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500.

Does the MarketBeat Community prefer EL or PBH?

Estée Lauder Companies received 700 more outperform votes than Prestige Consumer Healthcare when rated by MarketBeat users. However, 70.30% of users gave Prestige Consumer Healthcare an outperform vote while only 67.67% of users gave Estée Lauder Companies an outperform vote.

Company	Underperform	Outperform
Estée Lauder Companies	Outperform Votes 1197 67.67%	Underperform Votes 572 32.33%
Prestige Consumer Healthcare	Outperform Votes 497 70.30%	Underperform Votes 210 29.70%

Which has higher earnings and valuation, EL or PBH?

Estée Lauder Companies has higher revenue and earnings than Prestige Consumer Healthcare. Estée Lauder Companies is trading at a lower price-to-earnings ratio than Prestige Consumer Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Estée Lauder Companies	$15.18B	1.39	$390M	-$1.95	-30.14
Prestige Consumer Healthcare	$1.12B	3.65	$209.34M	$4.27	19.32

Do analysts prefer EL or PBH?

Estée Lauder Companies presently has a consensus target price of $77.25, indicating a potential upside of 31.45%. Prestige Consumer Healthcare has a consensus target price of $93.33, indicating a potential upside of 13.13%. Given Estée Lauder Companies' higher probable upside, research analysts clearly believe Estée Lauder Companies is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Estée Lauder Companies	0 Sell rating(s)	18 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media favor EL or PBH?

In the previous week, Estée Lauder Companies had 27 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 39 mentions for Estée Lauder Companies and 12 mentions for Prestige Consumer Healthcare. Prestige Consumer Healthcare's average media sentiment score of 1.01 beat Estée Lauder Companies' score of 0.71 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Estée Lauder Companies	14 Very Positive mention(s)	5 Positive mention(s)	9 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is EL or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Estée Lauder Companies' net margin of -4.61%. Estée Lauder Companies' return on equity of 16.82% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Estée Lauder Companies	-4.61%	16.82%	4.00%
Prestige Consumer Healthcare	19.13%	12.36%	6.39%

Do insiders & institutionals hold more shares of EL or PBH?

55.2% of Estée Lauder Companies shares are held by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are held by institutional investors. 12.8% of Estée Lauder Companies shares are held by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Estée Lauder Companies beats Prestige Consumer Healthcare on 11 of the 20 factors compared between the two stocks.